San Jose, CA (PRWEB) June 30, 2009
Infusion pumps market stands immensely benefited by changing demographics, increased spending in the healthcare sector, innovations in treatment procedures, shift towards alternate sites of healthcare, and increased occurrences of a number of chronic diseases. Introduction of several innovative, technology intensive products, such as, CADD® ambulatory infusion pumps, have gained rapid recognition and acceptance, particularly in the US and European markets.
The infusion pumps market in the United States has historically been characterized by immense competition and cost containment measures exerted by Group Purchasing Organizations (GPOs), and hospitals that wield strong bargaining power. In addition, limited scope for incremental improvements in technology development, and the price fighter strategy adopted by manufacturers, especially in the mature product markets, limited revenue generation capacity, and expanded the installed base, necessitating manufacturers to focus on generating revenues through the sale of disposables, consumables, and administrative sets. In an attempt to gain market traction, manufacturers have shifted product differentiation from price to sophisticated features, such as, network software, and smart, intelligent pump options. The emergence of smart infusion pumps represents an illustrative example, where manufacturers compete on technology, software licensing, and provision of specialized services. Further, the market is expected to quickly recover any lost momentum caused due to recessionary climate with growth reverting back to strong fundamentals revolving around rising rates of chronic diseases, and the ever-present need for safer and advanced infusion technologies.
As stated in the new market research report, the United States and Europe collectively dominate the global Infusion Pumps market. Strong opportunities for growth lie in the homecare sector with patient controlled systems (PCA) and ambulatory infusion pumps poised for a period of robust growth. In volume terms, United States represent the largest market for Implantable Infusion Pumps, driven largely by developments in chemotherapy drugs, shift towards alternate care, increased installation base, cost effective devices, and equipment upgradations.
Rising instances of diabetes worldwide, growing patient awareness over effective management of the disease, and the desire and emphasis to lead active lifestyles are key factors driving up the demand for insulin infusion pumps. Insulin infusion pumps, a breakthrough in diabetes disease management, eliminates dosage administrational errors, provides optimum control over blood glucose levels, closely emulates the normal functioning of the pancreas, and offers the ability to maintain active, normal lifestyles. Insulin pumps additionally score higher over injection treatment, since the intensive disease management benefits it offers reduces the chances of developing complications, such as, diabetic Retinopathy, Nephropathy, Neuropathy, and Hypoglycaemia.
Key players dominating the marketplace include Animas Corporation, Baxa Corporation, Baxter Healthcare Corporation, B.Braun Melsungen AG, CareFusion Corporation, Codman & Shurtleff Inc., DJO Incorporated, Excelsior Medical, Hospira Inc., I-Flow Corporation, Insulet Corporation, LMA International, Medtronic Inc., Moog Inc., Curlin Medical Inc., Nipro Medical Corporation, Roche Holdings AG, Smiths Medical, and Stryker Instruments among others.
The report titled "Infusion Pumps: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of industry overview, product overview, product introductions/innovations, profiles of major players, and recent industry activity. The report analyzes market data and provides analytics in both value and volume sales for major geographic markets such as US, Canada, Japan, France, Germany, Italy, the UK, and rest of world. The study also analyzes the Infusion Pumps market by the following product segments - General Purpose Infusion Pumps - Large Volume Infusion Pumps, Portable (Ambulatory) Infusion Pumps, and Syringe Infusion Pumps; and Specialty Infusion Pumps - Implantable Infusion Pumps, and Insulin Infusion Pumps.
For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Infusion_Pumps_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Email press (at) StrategyR (dot) com
Web Site http://www.StrategyR.com/